Intelligent Bio Solutions Inc.
INBS
$2.15
-$0.05-2.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -20.49% | 9.57% | 64.25% | 80.22% | 114.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -20.49% | 9.57% | 64.25% | 80.22% | 114.21% |
| Cost of Revenue | -31.94% | -6.79% | -122.28% | 52.19% | 401.60% |
| Gross Profit | 12.00% | 49.29% | 1,544.35% | 440.91% | -18.36% |
| SG&A Expenses | 6.11% | -20.68% | 9.80% | 27.75% | -24.06% |
| Depreciation & Amortization | 5.13% | -2.34% | 67.75% | -20.08% | -27.10% |
| Other Operating Expenses | 12.79% | -14.74% | -99.74% | 28.80% | 43.18% |
| Total Operating Expenses | 4.23% | 8.28% | 14.79% | 30.08% | 10.77% |
| Operating Income | -13.71% | -7.87% | -6.49% | -20.71% | 6.55% |
| Income Before Tax | -14.19% | -10.79% | -4.64% | 52.98% | -362.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.19% | -10.79% | -4.64% | 52.98% | -362.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.96% | 27.78% | -11.20% | 12.35% | 3.08% |
| Net Income | -14.21% | -10.74% | -4.71% | 53.06% | -368.28% |
| EBIT | -13.71% | -7.87% | -6.49% | -20.71% | 6.55% |
| EBITDA | -14.63% | -8.99% | -2.20% | -28.29% | 10.03% |
| EPS Basic | 76.09% | 94.36% | 96.38% | 97.91% | 62.68% |
| Normalized Basic EPS | 76.08% | 94.36% | 96.30% | 94.11% | 62.41% |
| EPS Diluted | 76.09% | 94.36% | 96.38% | 97.91% | 62.68% |
| Normalized Diluted EPS | 76.08% | 94.36% | 96.30% | 94.11% | 62.41% |
| Average Basic Shares Outstanding | 377.60% | 1,862.46% | 2,795.90% | 2,150.97% | 1,154.56% |
| Average Diluted Shares Outstanding | 377.60% | 1,862.46% | 2,795.90% | 2,150.97% | 1,154.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
